Literature DB >> 363949

B lymphocyte subpopulations separated by velocity sedimentation. II. Characterization of tolerance susceptibility.

J M Teale, M C Howard, G J Nossal.   

Abstract

Neonatal and adult splenic B lymphocyte subpopulations, separated by velocity sedimentation, were tested in an in vitro splenic focus assay for their susceptibility to tolerance induction with hapten-protein conjugates. At least two tolerizable B cell subsets have been defined in the neonatal spleen; one comprising the slowly sedimenting, small lymphocytes and the other comprising the very rapidly sedimenting, large lymphocytes. In addition, a rapidly sedimenting large B cell subset in the adult spleen was found to be highly susceptible to tolerance induction. It was suggested that the inability to detect this susceptibility in unfractionated adult spleen was due to the low proportion of these very large lymphocytes in the total spleen cell population. The tolerizable B cell subsets presently defined probably represent the least mature B lymphocytes detectable in the splenic focus assay.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 363949

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Clonal anergy: persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen.

Authors:  G J Nossal; B L Pike
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

2.  Mitogenic activity of water-soluble adjuvant obtained from Bacterionema matruchotii.

Authors:  T Nitta; S Okumura; M Nakano
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

3.  Ontogenic development of B-lymphocyte function and tolerance susceptibility in vivo and in an in vitro organ culture system.

Authors:  J M Teale; T E Mandel
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

4.  Late clonal selection and expansion of the TEPC-15 germ-line specificity.

Authors:  J Fung; H Köhler
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.